Glycaemic efficacy and safety of linagliptin compared to basal bolus insulin regimen in non-cardiac surgical patients with type 2 diabetes: Linagliptin-Surgery trial

被引：0
|
作者：
Umpierrez, G. [1 ]
Vellanki, P. [1 ]
Rasouli, N. [2 ]
Baldwin, D. [3 ]
Alexanian, S. [4 ]
Anzola, I. [1 ]
Urrutia, M. [1 ]
Gomez, P. [1 ]
Cardona, S. [1 ]
Wang, H. [1 ]
Pasquel, F. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Univ Colorado, Med, Denver, CO 80202 USA
[3] Rush Univ, Chicago, IL 60612 USA
[4] Boston Univ, Med, Boston, MA 02215 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
769
引用
收藏
页码：S377 / S378
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
    Vellanki, Priyathama
    Cardona, Saumeth
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Pasquel, Francisco J.
    Davis, Georgia M.
    Fayfman, Maya
    Migdal, Alexandra
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES CARE, 2022, 45 (10) : 2217 - 2223
  • [32] Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes Basal Plus Trial
    Umpierrez, Guillermo E.
    Smiley, Dawn
    Hermayer, Kathie
    Khan, Amna
    Olson, Darin E.
    Newton, Christopher
    Jacobs, Sol
    Rizzo, Monica
    Peng, Limin
    Reyes, David
    Pinzon, Ingrid
    Fereira, Maria Eugenia
    Hunt, Vicky
    Gore, Ashwini
    Toyoshima, Marcos T.
    Fonseca, Vivian A.
    DIABETES CARE, 2013, 36 (08) : 2169 - 2174
  • [33] Randomized Controlled Trial on the Efficacy of Supplemental Rapid-Acting Insulin during Basal-Bolus Regimen in Non-ICU Patients with Type 2 Diabetes
    Vellanki, Priyathama
    Cardona, Saumeth
    Urrutia, Maria A.
    Galindo, Rodolfo J.
    Davis, Georgia
    Haw, J. Sonya
    Fayfman, Maya
    Migdal, Alexandra
    Guo, Yi
    Pasquel, Francisco J.
    Umpierrez, Guillermo E.
    DIABETES, 2020, 69
  • [34] Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis
    Zinman, Bernard
    Ahren, Bo
    Neubacher, Dietmar
    Patel, Sanjay
    Woerle, Hans-Juergen
    Johansen, Odd Erik
    CANADIAN JOURNAL OF DIABETES, 2016, 40 (01) : 50 - 57
  • [35] The efficacy and safety of linagliptin in Patients with Type 2 diabetes with or without renal disease: Results of a comprehensive Phase 3
    Cooper, M.
    von Eynatten, M.
    Emser, A.
    Patel, S.
    Woerle, H. J.
    Katsadze, V.
    DIABETES & METABOLISM, 2012, 38 : A103 - A103
  • [36] Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
    Ádám G. Tabák
    John Anderson
    Pablo Aschner
    Minzhi Liu
    Aramesh Saremi
    Peter Stella
    Francisco J. Tinahones
    Carol Wysham
    Juris J. Meier
    Diabetes Therapy, 2020, 11 : 305 - 318
  • [37] Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
    Tabak, Adam G.
    Anderson, John
    Aschner, Pablo
    Liu, Minzhi
    Saremi, Aramesh
    Stella, Peter
    Tinahones, Francisco J.
    Wysham, Carol
    Meier, Juris J.
    DIABETES THERAPY, 2020, 11 (01) : 305 - 318
  • [38] Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease
    Groop, Per-Henrik
    Perkovic, Vlado
    Cooper, Mark
    Crowe, Susanne
    Lee, Jisoo
    Patel, Sanjay
    Von Eynatten, Maximilian
    DIABETES, 2014, 63 : A264 - A264
  • [39] Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes
    Jung, S.
    Ott, C.
    Kannenkeril, D.
    Bosch, A.
    Karg, M.
    Striepe, K.
    Bramlage, P.
    Schmieder, R. E.
    DIABETOLOGIA, 2019, 62 : S357 - S358
  • [40] Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    Yang, Wenying
    Xu, Xiangjin
    Lei, Tao
    Ma, Jianhua
    Li, Ling
    Shen, Jie
    Ye, Binqi
    Zhu, Sandy
    Meinicke, Thomas
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 642 - 647
12345